In simple terms, GLP-1 therapies may influence the gut microbial environment, and microbial metabolites may also influence satiety, glucose regulation, inflammation, and gut signaling
When paired with GLP-1like in dual agonists such as tirzepatide and the triple agonist retatrutideit becomes a powerful driver of weight loss, improved glucose control, and insulin sensitivity
Most trials focus on kids 12+ for obesity management first, then diabetes
The study also confirms that resistance exercise may reduce the decline in muscle strength in middle-aged women
Today, were thrilled to launch WeightWatchers RxFlexFund, a new model that combines direct manufacturer pricing, flexible employer cost-sharing, with WeightWatchers proven behavioral and clinical support for GLP-1 medications